Pfizer Seeks U.S. Authorization of COVID-19 Booster Shots for 16, 17 Year Olds

Pfizer Inc’s Chief Executive Officer Albert Bourla said on Tuesday the company has submitted a request to the U.S. Food and Drug Administration seeking the authorization for its COVID-19 booster doses for use in 16- and 17-year olds. Read More